CYP 3.85% 25.0¢ cynata therapeutics limited

Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-3

  1. 3,212 Posts.
    lightbulb Created with Sketch. 472
    .... so , in the interest of diplomacy , would you say that MSB got very good results , but that our's were even more very gooder ?
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.